# NIH Reporter #3U19CA264338-05S1

Advancing treatment and understanding of immunotherapy in glioblastoma

**Recipient:** University of California, San Francisco

**Award Amount:** $838,812.00
**Ceiling:** $838,812.00

**Awarded:** September 17, 2026

**Identifier:** 3U19CA264338-05S1

A National Cancer Institute grant supplement to support work on immunotherapy in glioblastoma at the University of California, San Francisco.

### Description

Supplemental activities within the scope of the parent grant; no changes.

[View original record](https://reporter.nih.gov/search/J7l2tQ4hHkqRePwGq3m5kA/project-details/11608606)